The aim of this randomized trial is to detect whether or not the use of Sildenafil citrate
therapy will increase the amniotic fluid volume expressed in term of amniotic fluid index
measured via ultrasound for fetuses of pregnancies complicated by oligohydramnios, and to
compare the outcomes of Sildenafil-treated pregnancies with similar pregnancies that will
remain Sildenafil-naïve.